• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
Thermo Scientific Stellar mass spectrometer

Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research

Thermo Fisher Scientific Inc. the world leader in serving science, today unveiled the Thermo Scientific™ Stellar™ mass spectrometer (MS), a new solution that combines fast throughput, high sensitivity, and ease of use to allow researchers to advance their translational omics research and make breakthrough discoveries more efficiently.

Read more →
Rika Plasma Donation SystemTM

FDA Clears Rika Plasma Donation System's Individualized Nomogram Feature

Terumo Blood and Cell Technologies a medical technology company, recently received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Rika Plasma Donation System™ with the iNomi™ Nomogram. This innovation means that plasma collection volume can be determined by an individual donor's height, weight and hematocrit level on the day they donate plasma.

Read more →
THESYS™ ACS ERGO synthesis column

Asahi Kasei Bioprocess Unveils THESYS ACS ERGO Synthesis Column

Generating cutting-edge therapeutics requires precision, safety, and efficiency from manufacturing equipment. The next generation of oligo manufacturing, the process of producing short sequences of nucleotides (building blocks of DNA or RNA), innovation from Asahi Kasei Bioprocess (AKB).

Read more →
Robotic system for cell therapy

Multiply Labs Unveils First Peer-Reviewed Study Showing that Robotic Cell Expansion

Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, Cytotherapy, the official journal of the International Society for Cell & Gene Therapy (ISCT), published a peer-reviewed research article focused on the performance of its proof-of-concept robotic system developed alongside a group of leading cell therapy organizations.

Read more →
Better cancer trials

Better cancer trials could be around the corner

Cold Spring Harbor Laboratory Associate Professor and Cancer Center member Tobias Janowitz led a COVID-19 clinical trial with Northwell Health in 2021. When he and Clinical Fellow Hassal Lee reviewed the data, a surprising trend emerged.

Read more →